Caribou Biosciences Company Information - Funding, Investors, and More

Caribou Biosciences

Caribou Biosciences is a Berkeley, California鈥攂ased private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz.

Funding Rounds

$489.4m

Money raised

Caribou Biosciences is a Berkeley, California鈥攂ased private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz.

Name	Email	Phone	Social networks
Ja* Be**	-	-	-
Je* Do****	*@berkeley.edu	-	linkedin twitter facebook instagram
Ra**** Ha*	-	-	linkedin
Ma** Ji*	-	-	linkedin twitter

Name	Email	Phone	Social networks
Ra**** Ha*	-	-	linkedin
An** Gu*	-	-	linkedin
Na Sa***	-	-	linkedin
Sc* Br*	-	-	linkedin
Na*** Wh	-	-	linkedin instagram
Ra* Zh***	-	-	linkedin instagram
Da Ri**	-	-	linkedin

Name	Email	Phone	Social networks
Ra**** Ha*	-	-	linkedin
Ja* O锟�	-	-	linkedin instagram

The company Caribou Biosciences has raised a total of $319m in funding over 7 rounds.

2022

Caribou Biosciences Series A round $15m

2021

Caribou Biosciences Initial public offering (IPO) $304m

Caribou Biosciences Series A Funding Round March 2015 $11m

Caribou Biosciences Series C round, March 2021 $115m

Caribou Biosciences Series B round, May 2016 $30m

Caribou Biosciences Venture round, September 2014 $11.5m

Caribou Biosciences Venture Funding Round September 2014 $2.9m

Caribou Biosciences is active in the following industries:

Yield10 Bioscience

$489.4m